The TAVR space is heavily dominated in the U.S. and Europe by Edwards Lifesciences and Medtronic, but Meril said there is enough room in the market for more players.
News & Features
Bayer plans to discontinue sales of the Essure birth control implant in the United States, citing a decline in U.S. sales of the device.
Oxford Performance Materials (OPM) has won a first-of-its-kind FDA clearance for its 3-D printed facial implant.
The Marlborough, MA-based company is set to swoop in and pick up Claret Medical, an embolic protection specialist, in a deal worth $270 million.
A needle-free blood collection device has been adopted by a hospital system following its evaluation of the technology and the procedure in multiple inpatient units.
Viz.ai is the latest company in the artificial intelligence space to draw attention from investors and raised about $21 million in a series A round.
Through its new MiniMed 670G performance guarantee program, Medtronic said it will provide flat-fee reimbursements up to $25,000 per pump over four years of qualifying diabetes-related inpatient hospitalization and emergency room admissions for eligible in-network patients in the United States.
Abbott Laboratories reported a strong second quarter overall, but in medical devices, the company appears to be losing share in cardiac rhythm management and neuromodulation. Could Abbott's loss in these markets be Medtronic or Boston Scientific's gain?
Could force sensors provide the necessary human-like touchpoints for smart-connected medical devices?
Though they are best known as a popular candy, gummy bears have found a different use as a transport for microelectrodes with increased biocompatibility, thanks to researchers from the Technical University of Munich . A team there, collaborating with researchers at Germany’s Forschungszentrum...
Baxter said it is evaluating other potential locations, including contract manufacturers, to support its supply needs if necessary.